Literature DB >> 1713465

Proliferative activity following induction chemotherapy in squamous cell carcinoma of the head and neck. A histopathological and immunohistochemical study using monoclonal antibodies.

R Bettinger1, M Loerz, E Meyer-Breiting.   

Abstract

Forty-six patients with advanced head and neck squamous cell carcinomas received two courses of chemotherapy with cisplatinum and bleomycin before undergoing cancer surgery. After surgery, histological serial sections of the resection specimens were examined. Biopsies from each resected specimen were shock-frozen for immunohistochemical examinations using the monoclonal antibodies Ki-67 and RPN-511, which are associated with cell proliferation. In no case did the morphologic analysis demonstrate complete tumor regression after chemotherapy. Thirty-seven patients showed partial tumor regressions histologically, as seen by tumor shrinkage of more than 50%. Nine of the specimens showed only minor regressions, with shrinkage less than 50%. The immunostaining of the frozen sections revealed in all cases the expressions of the Ki-67 nuclear antigen and the presence of specific transferrin (RPN-511) receptors in the proliferative compartments of the carcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713465     DOI: 10.1007/bf00173663

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  The cell cycle associated change of the Ki-67 reactive nuclear antigen expression.

Authors:  K Sasaki; T Murakami; M Kawasaki; M Takahashi
Journal:  J Cell Physiol       Date:  1987-12       Impact factor: 6.384

2.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

3.  New antibiotics, bleomycin A and B.

Authors:  H Umezawa; K Maeda; T Takeuchi; Y Okami
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

4.  [Formation of giant cells in oral squamous cell carcinoma during bleomycin treatment: enzymehistochemical, electronmicroscopic and ultrahistochemical investigations (author's transl)].

Authors:  A Burkhardt; G Bommer; J O Gebbers; W J Höltje
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-02-16

5.  Treatment of advanced squamous cell carcinomas of the head and neck with initial combination chemotherapy prior to surgery and/or radiotherapy: five-year survival data.

Authors:  H J Shaw; L A Price; B T Hill
Journal:  J Laryngol Otol       Date:  1984-01       Impact factor: 1.469

Review 6.  [Results of primary antineoplastic chemotherapy in advanced keratinizing squamous epithelial carcinomas of the head and neck region].

Authors:  H Weidauer; R Singer
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1981-04

7.  The effect of chemotherapy in relation to pathohistological tumour grading in head and neck cancer.

Authors:  K Böheim; H Spoendlin
Journal:  Arch Otorhinolaryngol       Date:  1983

8.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

9.  Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma.

Authors:  S M Shapshay; W K Hong; J S Incze; K Yamaguchi; R Bhutani; C W Vaughan; M S Strong
Journal:  Am J Surg       Date:  1978-10       Impact factor: 2.565

10.  [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].

Authors:  A Klima; C von Ilberg; L Bergmann; A Zoubek; T Klippstein; P S Mitrou; S Szepesi
Journal:  HNO       Date:  1987-02       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.